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Abstract
Background: Dengue re-emerges in Singapore despite decades of effective vector control; the infection
predominantly afflicts adults. Severe dengue not fulfilling dengue hemorrhagic fever (DHF) criteria according to
World Health Organization (WHO) 1997 guideline was increasingly reported. A new WHO 2009 guideline
emphasized warning signs and a wider range of severe dengue manifestations. We aim to evaluate the utility of
these two guidelines in confirmed adult dengue fatalities.
Methods: We conducted a multi-center retrospective chart review of all confirmed adult dengue deaths in
Singapore from 1 January 2004 to 31 December 2008.
Results: Of 28 adult dengue deaths, median age was 59 years. Male gender comprised 67.9% and co-morbidities
existed in 75%. From illness onset, patients presented for admission at a median of 4 days and death occurred at a
median of 12 days. Intensive care admission was required in 71.4%. Probable dengue was diagnosed in 32.1% by
WHO 1997 criteria and 78.6% by WHO 2009. The earliest warning sign was persistent vomiting at a median of
1.5 days. Hematocrit change ≥20% concurrent with platelet count <20 × 10^9/L was associated with the shortest
interval to death at a median of 3 days. Only 35.7% of death cases fulfilled DHF criteria by WHO 1997 versus severe
dengue in 100.0% by WHO 2009 criteria. Deaths were due to shock and organ failure. Acute renal impairment
occurred in 71.4%, impaired consciousness 57.1% and severe hepatitis 53.6%.
Conclusions: In our adult fatal dengue cohort, WHO 2009 criteria had higher sensitivity in diagnosing probable
dengue and severe dengue compared with WHO 1997. As warning signs, persistent vomiting occurred early and
hematocrit change ≥20% concurrent with platelet count <20 × 10^9/L preceded death most closely.
Background
Dengue is the most important arthropod-borne viral
disease in humans. The World Health Organization
(WHO) has estimated that 1.8 billion people, or more
than 70% of the global at-risk population, live in the
WHO Southeast Asia and the Western Pacific regions
which account for nearly 75% of current global disease
burden from dengue [1]. Singapore, a developed island
city-state in Southeast Asia has experienced resurgent
dengue epidemics since the 1990s after previous decades
of vector control effectively reduced the Aedes house
index [2]. In addition, dengue infections in Singapore in
recent years have shifted from primarily a childhood
disease to that of adults [2]. With this resurgence, the
classification of dengue cases for hospitalization and
clinical management has gained importance.
The WHO 1997 guideline on management of dengue
hemorrhagic fever (DHF) differentiates dengue manifes-
tation into dengue fever (DF) and DHF, where plasma
leakage underlies the pathophysiology of DHF [3]. This
differentiation of dengue disease severity relied on data
gathered from pediatric studies. Severe dengue especially
in adults not fulfilling DHF criteria are being increas-
ingly recognized [4]. Both Singapore and Puerto Rico
reported confirmed adult dengue fatalities not fulfilling
DHF and dengue shock syndrome (DSS) classification
[5-7]. Persistent vomiting and abdominal pain were
identified in a Cuban study as the most frequent warn-
ing signs [8], and tachycardia on admission was the only
predictor of death in a Singapore case-control study [5].
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gastro-intestinal symptoms in defining probable dengue
and warning signs as predictors of severe dengue, and
re-defined severe dengue beyond DHF and DSS [1].
This study describes a large cohort of adult dengue
deaths in Singapore confirmed by dengue polymerase
chain reaction (PCR) assay and non-structural protein
1 (NS1), and evaluates the utility of the two WHO
guidelines 1997 and 2009 in confirmed adult dengue
fatalities. This is important to determine the effective-
ness of these guidelines in classifying dengue and severe
dengue cases.
Methods
We performed a multi-center retrospective observational
study of adult dengue deaths at all five major adult pub-
lic hospitals in Singapore from 1 January 2004 to 31
December 2008. Cases were identified through matching
positive dengue diagnostic test results with hospital
mortality records. Patients tested positive by dengue
PCR or NS1 as previously described [9,10], and died
within the same hospital admission, were included.
Probable dengue diagnosed with rapid dengue serology
was excluded due to lack of specificity [11].
Demographic, epidemiological, co-morbidity, serial
clinical and laboratory, radiological, treatment and out-
come data were obtained, and principal and secondary
discharge diagnoses were recorded. The duration of
acute illness was determined from the onset of fever,
and from the onset of symptoms preceding hospitaliza-
tion if fever was absent.
Institutional review boards of National Healthcare
Group (Tan Tock Seng Hospital, National University
Hospital and Alexandra Hospital) and Singhealth Group
(Singapore General Hospital and Changi General Hospi-
tal), Singapore, approved the study, which was funded
by the National Medical Research Council, Singapore.
All records examined were anonymized.
According to the WHO 1997 guideline, DF clinically
required the presence of fever and two or more of head-
ache, retro-orbital pain, myalgia, arthralgia, rash, hemor-
rhagic manifestations and leukopenia; DHF the presence
of all of fever, thrombocytopenia ≤100 × 10^9/L, any
bleeding, and plasma leakage manifesting as either
hematocrit change of ≥20%, clinical fluid accumulation
(e.g. pleural effusion or ascites), or hypoproteinemia;
and DSS the presence of one of rapid and weak pulse
with narrow pulse pressure <20 mmHg, or hypotension
for age in a patient with DHF.
Minor modifications to the WHO 2009 criteria were
made in this study. Probable dengue was defined as
fever and two of nausea or vomiting, rash, aches and
pain, leukopenia, and any warning sign. The tourniquet
sign was not performed in Singapore. Warning signs
were determined as: abdominal pain or tenderness, per-
sistent vomiting on at least two consecutive hospital
days, clinical fluid accumulation (pleural effusion or
ascites), mucosal bleed, lethargy or restlessness, any
hepatomegaly (instead of greater than 2 cm), and hema-
tocrit change of ≥20% with concurrent platelet nadir <
20 × 10^9/L or 50 × 10^9/L (instead of the qualitative
rapid change in hematocrit with rapid drop in platelet
count).
Severe dengue was present if any one of the following
was recorded:
(1) Plasma leakage evidenced by hematocrit change of
≥20%, pleural effusion or ascites, or hypoproteinemia,
leading to
(a) DSS (tachycardia, cold and clammy extremities,
capillary refill time greater than three seconds, weak or
undetectable pulse, narrow pulse pressure ≤20 mmHg,
or systolic blood pressure <90 mmHg or unrecordable
blood pressure), or
(b) Fluid accumulation with respiratory distress
(respiratory rate ≥30/minute, oxygen saturation ≤92% on
room air, or mechanical ventilation); or
(2) Severe bleeding manifesting as gastro-intestinal
bleeding or menorrhagia, or requirement for transfusion
of packed red blood cells or whole blood; or
(3) Severe organ involvement as follows:
(a) Serum alanine or aspartate transaminase ≥1000
units/L;
(b) Impaired consciousness;
(c) Acute renal impairment defined as serum creati-
nine > two times upper limit of normal [12]; or
(d) Myocarditis or encephalopathy/encephalitis.
For the statistical analysis, Fisher’s exact test was
applied to detect statistical difference between dichoto-
mous variables, while the Kruskal-Wallis test was used
to test for significant trend for continuous data. The
analysis was performed in SPSS version 16 (SPSS Inc.,
Chicago, IL, USA), with the level of significance set at a
two-tailed p value of <0.05.
Results
Clinical and epidemiological features of the cohort
There were 27 adult dengue deaths confirmed by
dengue PCR and one by NS1 from 1 January 2004 to
31 December 2008 in the five Singapore adult public
hospitals - six in 2004, nine in 2005, three in 2006, eight
in 2007 and two in 2008. The lowest estimated inci-
dence of adult dengue death was 6.8 per 10,000 dengue
cases, based on 41,234 notified dengue cases over this
period [13] (potential dengue deaths outside of the five
hospitals and those diagnosed with dengue serology
were not included). Males comprised 19 (67.9%) of the
deaths and the median age was 59 years (range, 21-86
years). Co-morbidities existed in 21 (75.0%) deaths; with
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betes mellitus in 9, nephropathy in 8, chronic lung dis-
eases in 4, and 3 each with cancer, corticosteroid use
and hyperlipidemia, and 1 with liver disease.
Admission diagnoses recorded in the medical notes in
emergency department were dengue and dengue-related
in eight cases; namely dengue (6 cases), DSS (1) and
viral fever (1). The median duration from illness onset
to hospital admission was 4 days (range, 1-10 days),
from admission to the taking of the positive dengue test
sample was 2.5 days (range, 1-11 days). Twelve patients
survived more than seven days after positive dengue
test, of which five of them survived more than 2 weeks.
The median duration from illness onset to death was 12
days (range, 2-38 days) and from the positive dengue
test to death was 6 days (range, 1-32 days). The median
length of hospital stay was 8.5 days (range, 2-34 days);
fifteen patients were hospitalized for more than seven
days and seven patients more than 14 days before death.
Two of those seven cases developed bacteremia. Dengue
was stated as primary cause of death or primary dis-
charge diagnosis in 16 subjects - 6 were diagnosed as
DSS, 6 DHF and 4 DF. Autopsy was not performed in
any patient.
Twenty (71.4%) patients required admission to inten-
sive care units (ICU), three of whom directly from
emergency department. The median duration from hos-
pital to ICU admission was 3 days (range, 1-9 days).
The median duration of ICU stay was 3 days (range, 1-
32 days). For the entire cohort, mechanical ventilation
was needed in 4 cases, inotropic support 14, blood
transfusion 8, and antibiotic 23.
Bacteremia was documented for four (14.3%) patients
at a median duration of 6.5 days (range, 2-22 days) from
hospital admission and 1.5 days (range, 1-21 days) from
dengue diagnosis. These included Pseudomonas aerugi-
nosa (1), methicillin-resistant Staphylococcus aureus (2),
and alpha-hemolytic streptococcus (1).
Clinical features at presentation and within seven days of
dengue diagnosis
Reported fever was present in 21 (75.0%) at presenta-
tion, increasing to 25 (89.3%) around the time of dengue
diagnosis. Recorded temperature of ≥37.5°C was present
at presentation in 19 (67.9%) and ≥38.0°C in 13 (46.4%)
cases, and within seven days of dengue diagnosis in 25
(89.3%) and 21 (75%) cases respectively. Given the older
age of our cohort, the lower temperature cut-off of
≥37.5°C was more sensitive. Taken together, reported
fever or recorded temperature of ≥37.5°C was present in
24 (85.7%) at presentation, increasing to 27 (96.4%)
within seven days of dengue diagnosis.
Table 1 showed the diagnostic criteria for probable
dengue according to the WHO 1997 and 2009
guidelines. At presentation, the WHO 1997 criteria for
probable dengue were fulfilled in only 4 (14.3%) cases,
and the WHO 2009 criteria in 17 (60.7%) cases. Within
seven days of dengue diagnosis, the WHO 1997 was
present in 9 cases (32.1%) versus WHO 2009 in 22
(78.6%).
The commonest warning sign at presentation accord-
ing to the WHO 2009 criteria was lethargy in 11
(39.3%), and hematocrit change of ≥20% with concur-
rent platelet count of <50 × 10^9/L was the commonest
(20 [71.4%]) within seven days of dengue diagnosis
(Table 1). Significant increase from hospital presentation
to within seven days of dengue diagnosis was noted for
fluid accumulation (from 3 [7.1%] to 13 [46.4%], p =
0.002), hematocrit change of ≥20% with concurrent pla-
telet count of <50 × 10^9/L (from 1 [3.6%] to 20
[71.4%], p < 0.001) and concurrent platelet count of <20
× 10^9/L (from 1 [3.6% to 14 [50.0%], p < 0.001), and
any warning sign (from 19 [67.9%] to 27 [96.4%], p =
0.012).
Figures 1 and 2 show the interval from illness onset to
developing warning signs, and from developing warning
signs to death respectively. The interval from illness
onset to developing warning signs was shortest for per-
sistent vomiting (median 1.5 days), followed by lethargy
and hematocrit change of ≥20% (median 5 days). The
interval from developing warning signs to death was
shortest for hematocrit change of ≥20% with concurrent
platelet count of <20 × 10^9/L (median 3 days). The dif-
ference in intervals from illness onset to developing
warning signs was statistically significant, but not for
the intervals from developing warning signs to death.
Comparison of WHO 1997 and 2009 criteria for defining
severity of dengue
In the WHO 1997 guideline, severe dengue was mainly
defined as DHF and DSS, with plasma leakage as the
underlying pathogenesis. As shown in Table 2, DHF cri-
teria were only fulfilled in 10 (35.7%); fever was present
in 27 (96.4%), thrombocytopenia 26 (92.9%), plasma
leakage 28 (100%) and bleeding 10 (35.7%). If bleeding
was excluded, the WHO 1997 criteria would be fulfilled
in all cases. Dengue shock syndrome defined in the
WHO 1997 criteria was present in 8 (28.6%). In com-
parison, severe dengue defined by the WHO 2009 cri-
teria was fulfilled in 28 (100.0%). Among the categories
of severe dengue defined by the WHO 2009 guideline
(Table 3), renal impairment was the commonest (20
[71.4%]), followed by impaired consciousness (16
[57.1%]) and severe elevation of transaminases ≥1000
units/L (15 [53.6%]). Hypoproteinemia was present in 25
(89.3%) but only two cases did not have hematocrit
change ≥20% or fluid accumulation. The WHO 2009
guideline classified plasma leakage with tachycardia
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in 21 [75.0%]) as DSS but this accounted for only two
cases (Table 3).
Discussions and Conclusions
Singapore experienced large dengue epidemics in the past
decade affecting predominantly adults [13]. This shift from
childhood to adult illness was attributed to lower herd
immunity and transmission outside home [2]. Epidemiolo-
gical data showed adults were at lower risk of DHF than
children [2,14]. Identifying dengue cases, and severe den-
gue cases among them, are important to allow for targeted
clinical management and close monitoring. Difficulties in
applying the WHO 1997 DHF criteria reported by many
countries led to a new WHO guideline in 2009 focussing
on recognizing warning signs and re-defining severe den-
gue [1,4,15,16]. We found that the diagnostic criteria for
probable dengue from the WHO 2009 guideline identified
78.6% of our adult confirmed dengue deaths compared
with 32.1% for the WHO 1997 criteria. In addition,
throughout the hospital admissions, the WHO 1997 DHF
criteria could only be fulfilled in 35.7% of cases, mainly due
to the lack of clinical bleeding, while the WHO 2009 cri-
teria classified all cases as severe dengue.
As for the importance of individual warning signs in
dengue deaths, a retrospective study in Puerto Rico
Table 1 Relevant clinical and laboratory data at hospital presentation and within seven days of dengue diagnosis
No.(%) of patients
at presentation
No.(%) of patients
within seven days
of positive dengue
p*
WHO 1997 criteria for probable dengue
Fever/temperature ≥37.5°C plus two or more of the following: 4 (14.3) 9 (32.1) 0.205
Fever:
Fever symptom 21 (75.0) 25 (89.3) 0.296
Temperature ≥37.5°C 19 (67.9) 25 (89.3) 0.101
Symptom/temperature ≥37.5°C 24 (85.7) 27 (96.4) 0.352
Headache 3 (10.7) 4 (14.3) 1.000
Retro-orbital pain 0 (0.0) 0 (0.0) na
Myalgia 7 (25.0) 9 (32.1) 0.768
Arthralgia 0 (0.0) 2 (7.1) 0.491
Rash 1 (3.6) 3 (10.7) 0.611
Hemorrhagic manifestation 5 (17.9) 6 (21.4) 1.000
Leukopenia 6 (21.4) 11 (39.3) 0.245
WHO 2009 criteria for probable dengue
Fever symptom/temperature ≥37.5°C and two of the following: 17 (60.7) 22 (78.6) 0.245
Fever symptom/temperature ≥37.5°C 24 (85.7) 27 (96.4) 0.352
Nausea or vomiting 10 (35.7) 10 (35.7) na
Rash 1 (3.6) 3 (10.7) 0.611
Aches and pain 18 (64.3) 19 (67.9) 1.000
Leukopenia 6 (21.4) 11 (39.3) 0.611
Any warning sign 19 (67.9) 27 (96.4) 0.012
WHO 2009 criteria for warning signs
Abdominal pain or tenderness 9 (32.1) 10 (35.7) 1.000
Persistent vomiting ≥2 days 0 (0.0) 2 (7.1) 0.491
Clinical fluid accumulation 2 (7.1) 13 (46.4) 0.002
Mucosal bleeding 0 (0.0) 4 (14.3) 0.112
Lethargy 11 (39.3) 16 (57.1) 0.285
Hepatomegaly 2 (7.1) 2 (7.1) na
Hematocrit change ≥20% 9 (32.1) 25 (89.3) <0.001
Hematocrit change ≥20% with platelet <50 × 10^9/L 1 (3.6) 20 (71.4) <0.001
Hematocrit change ≥20% with platelet <20 × 10^9/L 1 (3.6) 14 (50.0) <0.001
Any warning sign 19 (67.9) 27 (96.4) 0.012
na = not applicable, WHO = World Health Organization
*Fisher’s exact test
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temperature change and abnormal mental status as four
major warning signs [7]. Similarly, in Cuba all twelve
fatalities had headache, persistent vomiting, malaise,
bleeding and shock [8]. In another Singapore study,
abdominal pain, and nausea and vomiting occurred in
half of adult dengue deaths [5]. In our study, the pre-
sence of any warning sign was the commonest diagnos-
tic criterion at hospital presentation (67.9%) apart from
fever, and within seven days of dengue diagnosis (27
[96.4%]). For individual warning signs, lethargy was the
commonest at hospital presentation (39.3%) but within
seven days of dengue diagnosis, hemoconcentration with
Figure 1 Interval from illness onset to warning signs.K r u s k a l -
Wallis test p < 0.05 (Circles represents ≥1.5 times Inter Quartile
Range [IQR] and dot represents ≥3 times IQR from median)
Figure 2 Interval from onset of warning signs to death. Kruskal-
Wallis test p > 0.05 (Circles represents ≥1.5 times Inter Quartile
Range [IQR] and dot represents ≥3 times IQR from median)
Table 2 WHO 1997 criteria for dengue hemorrhagic fever
(DHF) and dengue shock syndrome (DSS)
Criteria No.(%) of patients
DHF (fulfilling all 4 criteria): 10 (35.7)
DHF (fulfilling 3 criteria excluding bleeding): 28 (100.0)
Fever 27 (96.4)
Platelet ≤100 × 10^9/L 26 (92.9)
Any bleeding 10 (35.7)
Plasma leakage: 28 (100.0)
Hematocrit change ≥20% 25 (89.3)
Pleural effusion or ascites 13 (46.4)
Hypoproteinemia 25 (89.3)
DSS: 8 (28.6)
DHF, rapid pulse and narrow pulse pressure 5 (17.9)
Rapid pulse >100/minute 26 (92.9)
Narrow pulse pressure <20 mmHg 10 (35.7)
DHF and hypotension 8 (28.6)
Hypotension <90 mmHg 21 (75.0)
WHO = World Health Organization
Table 3 WHO 2009 criteria for severe dengue
Criteria No.(%) of
patients
Severe dengue 28 (100.0)
Severe plasma leakage (hematocrit change ≥20%,
fluid accumulation, hypoproteinemia)
28 (100.0)
Severe plasma leakage (hematocrit change ≥20%,
fluid accumulation)
26 (92.9)
Shock:
Shock (tachycardia or narrow pulse pressure
or hypotension)
28 (100.0)
Shock (narrow pulse pressure or hypotension) 26 (92.9)
Tachycardia >100/minute 26 (92.9)
Narrow pulse pressure <20 mmHg 10 (35.7)
Hypotension <90 mmHg 21 (75.0)
Fluid accumulation with respiratory distress 9 (32.1)
Significant bleeding: 10 (35.7)
Gastrointestinal tract 3 (10.7)
Menorrhagia 0 (0.0)
Transfusion of packed red cells or whole
blood
8 (28.6)
Impaired consciousness: 16 (57.1)
Coma 1 (3.6)
Drowsiness 13 (46.4)
Confusion 4 (14.3)
Severe gastrointestinal involvement: 3 (10.7)
Persistent vomiting ≥2 days 2 (7.1)
Jaundice 3 (10.7)
Severe organ involvement: 24 (85.7)
ALT or AST ≥1000 units/L 15 (53.6)
Impaired consciousness 16 (57.1)
Serum creatinine >2x upper limit normal 20 (71.4)
Myocarditis 0 (0.0)
Encephalitis 0 (0.0)
ALT = alanine transaminase, AST = aspartate transaminase, WHO = World
Health Organization
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commonest (71.4%).
Our study also showed that impaired consciousness
i n c r e a s e df r o m7( 2 5 . 0 % )a th o s p i t a lp r e s e n t a t i o nt o
16 (57.1%) within seven days of dengue diagnosis. Rigau-
Perez et al reported a high proportion of impaired con-
sciousness at presentation and during disease progression
[7]. Other studies showed that dengue encephalopathy
was diagnosed in 0.5% of children with DHF, and that
impaired consciousness was associated with high mortal-
ity and multi-organ involvement [17,18]. The importance
in recognizing this sign in potentially severe dengue
should be emphasized.
Hemoconcentration was documented in 89.3% of our
patients while Cuba reported a similarly high 91.6% [8].
The WHO 2009 criteria lack clarity in quantifying the
degree and rate of change in hematocrit and platelet
count [1]. The combination of hematocrit change ≥20%
and concurrent thrombocytopenia <50 × 10^9/L and
<20 × 10^9/L were present in 71.4% and 50.0% of our
cases respectively. Our findings provide clinicians with
additional quantitative criteria as part of the new WHO
warning signs.
Our study also detailed the interval from illness onset
to developing warning signs and progression to death.
Persistent vomiting ≥ 2 days was the earliest warning
sign in our study followed by lethargy and hemoconcen-
tration. Notably, rapid progression to death in our
cohort occurred once hemoconcentration with thrombo-
cytopenia developed. In Cuba, vomiting was also one
of the commonest warning signs, and deterioration
occurred at a mean of 3.75 days from illness onset with
total illness duration of 7 days [8]. Hence, clinicians
should identify dengue patients with persistent vomiting
≥2 days for close monitoring for hematocrit change
≥20% concurrent with thrombocytopenia <20 × 10^9/L.
There were three earlier reports from Singapore on
adult dengue deaths. The age of the deceased in our
study and two recent studies [5,6] was older than a
m u c he a r l i e rr e p o r tb yC h a ne ta l[ 1 9 ]w i t hp o s s i b l e
shift of severe disease to older population. In our study,
75% had co-morbidities similar to other studies [7,8].
Asthma, diabetes mellitus and sickle cell disease have
been reported risk factors for DHF [20] and await vali-
dation in well-designed case control studies. In Cuba
white race was prevalent among fatal cases [8], but in
multi-racial Singapore, we found no evidence of ethnic
preponderance.
Our study included many elderly dengue deaths with a
median age of 59 years. Two studies on dengue in older
adults suggested fewer constitutional symptoms in these
patients [21,22]. Dengue shock syndrome was an inde-
pendent risk factor for mortality among the elderly in
Taiwan [21]. Multi-organ failure with renal impairment
was common in older patients [23]. A study from Tai-
wan reported that concurrent bacteremia occurred in
7.3% of all study subjects compared with 17.4% in the
elderly [21]. Bacteremia was detected in 14.3% in our
study, possibly due to older patients and prolonged hos-
pitalization (53.6% of our patients were hospitalized for
more than a week and 25% more than two weeks).
Recognizing and treating nosocomial infections in
complicated dengue infection should therefore be
emphasized.
There are some limitations of our retrospective study as
it depended on the thoroughness of clinicians’ documen-
tation. Documentation on bleeding including petechiae
was frequently missing, undermining the utility of WHO
1997 DHF criteria [24]. We did not perform the tourni-
quet test, which is part of WHO criteria for hemorrhagic
tendency. A Vietnamese study found that tourniquet pro-
vided additional diagnostic information only in 5% of
cases [25]. Information on dengue sero-type and primary
versus secondary dengue infection were lacking. However,
a prospective study may not be feasible given infrequent
adult dengue death, and our study provides a reflection
of the possible implications of use of the two WHO cri-
teria, and additional warning signs to be emphasized. Our
findings in a highly selected sample of adult dengue fatal-
ities need to be validated in less severe form of dengue
diseases in both adults and children. The predominance
of older adults in this study raises the need to include
older individuals in future vaccine studies.
In conclusion, our findings showed that the WHO
2009 guideline was effective in diagnosing probable and
severe dengue in adult dengue deaths. We have also
quantified the change in hematocrit and platelet count
as part of WHO 2009 warning signs, and have suggested
that impaired consciousness may be an important warn-
ing sign.
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